Earnings ·
Supernus Pharmaceuticals, Inc. announced that it will report its second quarter 2026 financial and business results…
SUPNSupernus, Inc.
Supernus Pharmaceuticals, Inc. announced that it will report its second quarter 2026 financial and business results after the market closes on Tuesday, August 4, 2026, and will host a conference call and webcast to discuss the results. Supernus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.